[Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
D000568:Amenorrhea / Q000188:drug therapy; D001941:Breast Diseases / Q000139:chemically induced; D002715:Chlormadinone Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000139:chemically induced; D008656:Mestranol / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced
D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D008656:Mestranol
Die Zweiphasentherapie mit Sequenz-Ovosiston im Rahmen der hormonalen Kontrazepation.